A skin tumor as a marker for a hereditary cancer syndrome: Muir-Torre syndrome

European Journal of Plastic Surgery

Volumn 28, Issue 4, 2005, Pages 276-280

  De Jongh, G J ^a,b   Keulers, B J ^c   Spauwen, P H M ^a   Blokx, W A M ^a   Gerritsen, M J P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Hereditary Cancer Syndrome; MTS; Muir Torre syndrome; Sebaceous tumor

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GERM LINE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUIR TORRE SYNDROME; PRIORITY JOURNAL; SEBACEOUS GLAND TUMOR;

EID: 28844444955     PISSN: 0930343X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00238-005-0766-7     Document Type: Article

References (27)

1. Abbott JJ, Hernandez-Rios P, Amirkhan RH, Hoang MP (2003) Cystic sebaceous neoplasms in Muir-Torre syndrome. Arch Pathol Lab Med 127:614
2. Akhtar S, Oza KK, Wright J (1999) Muir-Torre syndrome: case report of a patient with concur jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 41:681
3. Cohen PR, Kohn SR, Kurzrock R (1991) Association of sebaceous gland tumors and internal malignancies in Muir-Torre syndrome. Am J Med 90:606
4. Coldron J, Reid I (2001) Muir-Torre syndrome. J R Coll Surg Edinb 46:178
5. Dunlop MG, Farrington SM, Carothers AD et al (1997) Cancer risk associated with germ-line DNA mismatch repair gene mutations. Hum Mol Genet 10:105
6. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJA (2000) Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 6:1784
7. Finan MC, Connolly SM (1984) Sebaceous gland tumors and systemic disease: a clinicopathological analysis. Medicine (Baltimore) 63:232
8. Graefe T, Wollina U, Schulz HJ, Burgdorf W (2000) Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology 200(4):331
9. Harwood CA, Swale VJ, Bataille V et al (2001) An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 116:246
10. Kruse R, Rütten A, Lamberti C et al (1998) Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutation similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 63:63
11. Kruse R, Rütten A, Schweiger N et al (2003) Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol 120:858
12. Lynch HT, Fusaro RM (1999) The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): a classic obligation in preventive medicine. J Am Acad Dermatol 41:797
13. Lynch HT, Leibowitz R, Smyrk T et al (1999) Colorectal cancer and the Muir-Torre syndrome in a gypsy family. A review. Am J Gastroenterol 94:575
14. Mathiak M, Rutten A, Mangold E et al (2002) Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations. Establishment of immuno-histochemical analysis as a screening test. Am J Surg Pathol 26:338
15. Misago N, Narisawa Y (2000) Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermopathol 22:155
16. Miyaki M, Konishi M, Tanaka K et al (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:71
17. Muir EG, Bell AJY, Barlow KA (1967) Multiple primary carcinomata of the colon, duodenum and larynx associated with keratoacanthoma of the face. Br J Surg 54:191
18. Schwartz RA, Torre DP (1995)The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33:90
19. Spielvogel RL, DeVillez RL, Roberts LC (1985) Oral tretinoin therapy for familial Muir-Torre syndrome. J Am Acad Dermatol 12:475
20. Srivastava A, McKinnon W, Wood ME (2001) Risk of breast and ovarian cancer in women with strong family histories. Oncology 15:889
21. Suspiro A, Fidalgo P, Cravo M, Albuquerque C, Ramalho E, Leita Costa Mira F (1998) The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol 93:1572
22. Thorson AG, Knezetic JA, Lynch HT (1999) A century of progress in hereditary nonpolyposis colorectal cancer (Lynch Syndrome). Dis Colon Rectum 42:1
23. Torre D (1968) Society transactions: New York Dermatological Society, Oct 24, 1967. Arch Dermatol 98:549
24. Vasen HF, Meklin JP, Khan PM, Lynch HT (1991) The international collaborative group on heriditary NonPolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424
25. Vermeer MH, Neering H, Menko FH (1999) Twee patiënten met Muir-Torre syndroom. Ned Tijdschr Geneeskd 143:1980
26. Wu Y, Nystrom-Lahti M, Osinga J et al (1997) MSH2 or MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 18:269
27. Zouboulis CC, Boschnakow A (2001) Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 26:600